Purpose & ImportanceFollowing the passing of Colorado Bill SB22-205, twenty hemp and marijuana industry stakeholders were appointed to a Task Force to study intoxicating hemp products and make legislative recommendations. Out of the 180 applications received, our co-CEO, Dr. Priyanka Sharma, was invited as one of the stakeholders to the
(Watkins, CO – January 14, 2022) – Kazmira, a vertically integrated cannabinoid manufacturer with patent protected purification technology – who received a $50M minority investment from Perrigo, (NYSE: PRGO) in June of 2020 – today announced a significant strategic partnership with Companion Sciences to utilize its patent-pending CBD+Glucosamine formula and
(Watkins, CO – January 14, 2022) – Kazmira, a vertically integrated cannabinoid manufacturer with patent protected purification technology – who received a $50M minority investment from Perrigo, (NYSE: PRGO) in June of 2020 – today announced a significant strategic partnership with Companion Sciences to utilize its patent-pending CBD+Glucosamine formula and
Kazmira Joins ValidCare Clinical Safety Study for CBD ProductsKazmira and other CBD brands will assess CBD safety profiles with end-consumersKazmira, a technology based cannabinoid ingredient manufacturer, is partnering with ValidCare to participate in a large clinical safety study for CBD products. Kazmira joins the second cohort of brands participating in
Co-CEO & Co-Founder Dr. Priyanka Sharma spoke with Hemp Industry Daily on a roundtable with leaders and entrepreneurs throughout the industry.
They reflect on how COVID-19 has affected hemp and CBD companies, discussing the challenges, the changes, and the future of the industry.